Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 3
2004 6
2005 4
2006 5
2007 1
2008 3
2009 4
2010 4
2011 1
2012 1
2013 4
2014 9
2015 7
2016 2
2017 4
2018 10
2019 9
2020 12
2021 17
2022 8
2023 9
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. Among authors: d angelillo rm. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
Durvalumab in Small-Cell Lung Cancer.
Ramella S, Ippolito E, D'Angelillo RM. Ramella S, et al. Among authors: d angelillo rm. N Engl J Med. 2024 Dec 19;391(24):2385. doi: 10.1056/NEJMc2414036. N Engl J Med. 2024. PMID: 39693555 No abstract available.
Preventing Cardiotoxicity in Personalized Breast Irradiation.
Ippolito E, Greco C, Marrocco M, Rinaldi CG, Fiore M, Trodella LE, D'Angelillo RM, Ramella S. Ippolito E, et al. Among authors: d angelillo rm. Cancers (Basel). 2023 Oct 26;15(21):5153. doi: 10.3390/cancers15215153. Cancers (Basel). 2023. PMID: 37958327 Free PMC article.
The antineoplastic treatment in the elderly.
Vincenzi B, Santini D, Spoto S, Finolezzi E, D'Angelillo RM, La Cesa A, Tonini G. Vincenzi B, et al. Among authors: d angelillo rm. Clin Ter. 2002 May-Jun;153(3):207-15. Clin Ter. 2002. PMID: 12161983 Review.
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, Bruni A, Ingrosso G, D'angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Timon G, Arcidiacono F, Marvaso G, Jereczek-Fossa BA, Lancia A, Franzese C, Alongi F, Simontacchi G, Greto D, Bonomo P, Loi M, Frosini G, Burchini L, Desideri I, Meattini I, Valicenti RK, Livi L. Francolini G, et al. Among authors: d angelillo rm. Prostate Cancer Prostatic Dis. 2025 Feb 19. doi: 10.1038/s41391-025-00950-3. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 39972049
124 results